Cerebral Hemorrhage/etiology; Fibrinolytic Agents/adverse effects; Hemorrhagic Disorders/complications; International Normalized Ratio; Partial Thromboplastin Time; Stroke/drug therapy; Thrombolytic Therapy/adverse effects; Tissue Plasminogen Activator/adverse effects; Acute Disease; Aged; Aged, 80 and over; Anticoagulants/adverse effects; Cerebral Hemorrhage/chemically induced; Comorbidity; Diabetes Mellitus/epidemiology; Dyslipidemias/epidemiology; Female; Fibrinolytic Agents/therapeutic use; Hemorrhagic Disorders/blood; Hemorrhagic Disorders/chemically induced; Hospital Mortality; Humans; Hypertension/epidemiology; Male; Prospective Studies; Recombinant Proteins/adverse effects; Recombinant Proteins/therapeutic use; Risk Factors; Severity of Illness Index; Smoking/epidemiology; Stroke/complications; Stroke/diagnostic imaging; Tissue Plasminogen Activator/therapeutic use; Tomography, X-Ray Computed